EP1496747A1 - Method and composition for improving fertility health in female and male animals and humans - Google Patents
Method and composition for improving fertility health in female and male animals and humansInfo
- Publication number
- EP1496747A1 EP1496747A1 EP02728685A EP02728685A EP1496747A1 EP 1496747 A1 EP1496747 A1 EP 1496747A1 EP 02728685 A EP02728685 A EP 02728685A EP 02728685 A EP02728685 A EP 02728685A EP 1496747 A1 EP1496747 A1 EP 1496747A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- vitamins
- zinc
- selenium
- vitamin
- green tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/30—Copper compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Definitions
- This invention provides combinations of bioeffecting compounds for promoting fertility in men and women.
- the combinations include nutritional components that benefit fertility health. All the components have been studied separately, to determine their individual efficacy.
- the invention provides the first products to put these components together synergistically in women's and men's formulations.
- the invention provides combinations of beneficial bioeffecting compounds for promoting fertility in women.
- the invention provides a scientifically validated herbal/nutritional blend for women to improve infertility by helping to regulate the menstrual cycle and correct hormone imbalance (corpus luteum insufficiency) without increased chances of multiple births associated with drug therapy.
- the combination of amino acids, herbs, vitamins and minerals improves overall health and helps with many of the deficiencies that decrease fertility.
- Vitex agnus-castus (chasteberry)
- chasteberry The herb, Vitex agnus-castus (chasteberry) , enhances hormone balance in women by increasing luteinizing hormone and progesterone release and, therefore, ovulation frequency.
- the antioxidants, green tea, vitamin E, and selenium improve overall reproductive health.
- L-arginine an amino acid, stimulates the reproductive organs by improving circulation.
- Folic acid, vitamins B6 and B12, iron, zinc and magnesium help promote womens' fertility.
- the invention provides combinations of beneficial bioeffecting compounds for promoting fertility in men.
- Sperm are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging.
- Vitamins C and E, green tea, with or without coenzyme Q10 and selenium are all potent antioxidants that help improve sperm count and quality.
- Ferulic acid an antioxidant found in Dong Quai, also improves sperm quality.
- Zinc and B vitamins (B6, B12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motility.
- the amino acid, L-carnitine promotes formation of healthy sperm.
- L-carnitine fumarate is preferred.
- L-carnitine tartrate may be used.
- the invention provides synergistic action of the combinations .
- the two dietary supplements in male and female formulas are useful for men and women.
- the distinct combinations are taken by both members of a couple in which the female age is between 21 and 46.
- the distinct combinations are useful for couples who have tried for 6 months or more, up to three years, to become pregnant without success.
- patients take 2-4 capsules per day of the distinct formulas for three months.
- examples 1, 2, 3, provide preferred ranges of the combinations for men's formula considered in percent by weight :
- Example 2 Components Minimum % Maximum %
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pregnancy & Childbirth (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/010854 WO2003086080A1 (en) | 2002-04-08 | 2002-04-08 | Method and composition for improving fertility health in female and male animals and humans |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1496747A1 true EP1496747A1 (en) | 2005-01-19 |
| EP1496747A4 EP1496747A4 (en) | 2008-01-09 |
Family
ID=29247959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02728685A Withdrawn EP1496747A4 (en) | 2002-04-08 | 2002-04-08 | Method and composition for improving fertility health in female and male animals and humans |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1496747A4 (en) |
| JP (1) | JP2005522486A (en) |
| AU (1) | AU2002258727A1 (en) |
| CA (1) | CA2481603A1 (en) |
| WO (1) | WO2003086080A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102228565A (en) * | 2011-05-13 | 2011-11-02 | 潮州市泽润制药有限公司 | Preparation method and application of Vitex agnuscastus extract |
| RU2616521C1 (en) * | 2016-02-10 | 2017-04-17 | Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" | Composition for imporvement of human reproduction |
| RU2665636C2 (en) * | 2017-02-15 | 2018-09-03 | Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" | Composition for improvement of the male reproductive function |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005213147A (en) * | 2004-01-27 | 2005-08-11 | Ryoko Kumai | Activator for sperm of mammal and activating method |
| FR2884692B1 (en) | 2005-04-21 | 2009-08-14 | Formquest Ltd | FOOD SUPPLEMENT COMPRISING AN ASSOCIATION OF ANTIOXIDANT AGENTS AND CARNITINE, OBTAINED BY ENDOGENEOUS OR EXOGENOUS SYNTHESIS, AS AID FOR FERTILITY IN MAN AND WOMEN |
| CA2614210A1 (en) * | 2005-07-05 | 2007-01-11 | Adelaide Fertility Centre Pty Ltd | Methods and compositions for improving pregnancy outcome |
| FR2893848B1 (en) * | 2005-11-28 | 2011-11-11 | Physcience | PHYTOHORMONAL COMPOSITION AND ITS USE AS A HORMONAL SUBSTITUTE |
| AT503219B1 (en) * | 2006-02-03 | 2008-07-15 | Annerl Brigitte | COMBINATION PREPARATION BASED ON ANTIOXIDANTS TO IMPROVE THE SEED QUALITY |
| CN101167735A (en) * | 2006-10-27 | 2008-04-30 | 黄胜先 | Medicine for improving sperm quality and treating male infertility |
| FR2908604B1 (en) * | 2006-11-16 | 2013-06-28 | Physcience | FOOD SUPPLEMENT FOR THE PREVENTION OR FIGHT AGAINST THE FALL OF HAIR, ACNE, HIRSUTISM AND THE SOUTHERN SECRETION APOCRINE EXCESSIVE. |
| DE102007053369A1 (en) * | 2007-11-09 | 2009-07-02 | Alzchem Trostberg Gmbh | Use of a preparation containing a creatine-component and a further component of e.g. L-carnitine, acetyl-L-carnitine, arginine, glutathione, vitamin C and vitamin E, as a dietary supplement for improving the male fertility in vertebrates |
| ES2439868T3 (en) * | 2008-06-18 | 2014-01-27 | Roberto Fasani | Combined formulations for the treatment of male sterility |
| CN101879184B (en) * | 2009-05-07 | 2012-01-18 | 浙江医药股份有限公司新昌制药厂 | Medicinal composition for improving reproductive capability and preparation method and application thereof |
| FR2961697B1 (en) * | 2010-06-23 | 2013-01-18 | Granions Lab Des | COMPOSITION FOR REDUCING OXIDATIVE STRESS IN CASES OF MALE HYPOFERTILITY AND USE |
| FR2964834B1 (en) * | 2010-09-21 | 2012-09-28 | Marc Cohen | ANTI-OXIDIZING COMPOSITION FOR PREVENTING INFERTILITY IN MAN |
| AT13410U1 (en) * | 2010-12-09 | 2013-12-15 | Gonadosan Gmbh | Use of a ubiquinone component and a combined preparation to improve female fertility |
| DE102011052687A1 (en) * | 2011-08-12 | 2013-02-14 | Lohmann Animal Health Gmbh | Use of antioxidants |
| UA116587C2 (en) * | 2013-12-05 | 2018-04-10 | Альфасіґма С.п.А. | Composition useful for promoting female fertility |
| RU2686334C2 (en) * | 2017-08-31 | 2019-04-25 | Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") | Rectal medicinal agent for correction of spermatogenesis disorders in male infertility |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS522979B2 (en) * | 1972-09-29 | 1977-01-25 | ||
| US5308627A (en) * | 1990-08-07 | 1994-05-03 | Umbdenstock Jr Anthony J | Nutritional supplement for optimizing cellular health |
| JPH0840923A (en) * | 1994-07-28 | 1996-02-13 | Masatoshi Nakano | Nutrient-supplying agent |
| JP4653269B2 (en) * | 1999-02-23 | 2011-03-16 | 太陽化学株式会社 | Theanine-containing composition |
| US6242012B1 (en) * | 1999-10-19 | 2001-06-05 | Thomas Newmark | Herbal composition for promoting hormonal balance in women and methods of using same |
| US6261607B1 (en) * | 1999-10-19 | 2001-07-17 | Thomas Newmark | Composition for promoting prostate health containing selenium and herbal extracts |
| US6338862B1 (en) * | 2001-03-26 | 2002-01-15 | Sarfaraz K Niazi | Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors |
-
2002
- 2002-04-08 AU AU2002258727A patent/AU2002258727A1/en not_active Abandoned
- 2002-04-08 WO PCT/US2002/010854 patent/WO2003086080A1/en not_active Ceased
- 2002-04-08 JP JP2003583114A patent/JP2005522486A/en active Pending
- 2002-04-08 EP EP02728685A patent/EP1496747A4/en not_active Withdrawn
- 2002-04-08 CA CA002481603A patent/CA2481603A1/en not_active Abandoned
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102228565A (en) * | 2011-05-13 | 2011-11-02 | 潮州市泽润制药有限公司 | Preparation method and application of Vitex agnuscastus extract |
| RU2616521C1 (en) * | 2016-02-10 | 2017-04-17 | Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" | Composition for imporvement of human reproduction |
| RU2665636C2 (en) * | 2017-02-15 | 2018-09-03 | Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" | Composition for improvement of the male reproductive function |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002258727A1 (en) | 2003-10-27 |
| WO2003086080A1 (en) | 2003-10-23 |
| CA2481603A1 (en) | 2003-10-23 |
| JP2005522486A (en) | 2005-07-28 |
| EP1496747A4 (en) | 2008-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6497885B2 (en) | Method and composition for improving fertility health in female and male animals and humans | |
| WO2003086080A1 (en) | Method and composition for improving fertility health in female and male animals and humans | |
| JP7723387B2 (en) | Female Anti-Aging Agent | |
| US10092545B2 (en) | Nutritional supplements for improving female fertility | |
| US20090092687A1 (en) | Prhormone composition and method of use thereof | |
| JP2022121645A (en) | Menopause symptom preventing and/or improving composition | |
| Sadogh et al. | Herbal foodstuffs in Avicenna’s recommended diet to improve sperm quality and increase male fertility; an evidence-based approach | |
| US8663709B1 (en) | Composition and method for fertility therapy using nutritional supplements | |
| El-Zaher et al. | Ovarian activity and antioxidant indices during estrous cycle of Barki ewes under effect of thyme, celery and salinomycin as feed additives | |
| US20070104801A1 (en) | Fertility and anti-aging supplement for the fertility health of females and males | |
| US6989164B2 (en) | Method and composition for improving male fertility health | |
| Hosseini et al. | Effect of alcoholic extract of ginger during fetal life and breastfeeding on serum level of testosterone, LH, FSH and spermatogenic cells line in male mature offspring rats | |
| KR20070093437A (en) | Formulations and Treatments for Wellness | |
| KR101596728B1 (en) | Composition comprising zinc/red ginseng, octacosanol and vitamin for preventing and ameliorating andropause symptoms | |
| US8383165B1 (en) | Composition and method for fertility therapy using nutritional supplements | |
| CA3026026A1 (en) | Nutritional supplements for increasing male testosterone levels | |
| US20060009430A1 (en) | Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone | |
| US9775874B1 (en) | Method for treating symptoms of hormone imbalance | |
| US6673366B1 (en) | Breast enhancement system | |
| Gadekar et al. | Nutraceuticals and Female Sex Hormones | |
| AU2021104673A4 (en) | Poly herbal green tea supplement for improving implantation & fertility | |
| Refaie et al. | Impact of dietary supplementation of milk thistle (Silybum marianum) seed extract on doe rabbits performance | |
| JP2009256364A (en) | Method and composition for improving health state of fertilizing capacity of male and female animal and human | |
| Jaspreet et al. | Breastfeeding, the Benefits of Lactation for Nursing Mother's Health along with the Challenges Associated with Lactation and Use of Natural Milk Energizing Supplements | |
| Al-Jeborry et al. | Treatment of Sweating, Hot Flushing and Sleep Disturbance in Peri and Post Menopausal Women with Oral Pometone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20041108 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TRANT, AILEEN, SONTAG |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TRANT, AILEEN, SONTAG |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TRANT, AILEEN, SONTAG |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20071206 |
|
| 17Q | First examination report despatched |
Effective date: 20080529 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20090626 |